Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 52,236 | 52,309 | 51,047 | 176,642 | 23,995 |
Receivables | 150,307 | 122,030 | 79,048 | 59,739 | 50,676 |
Inventories | 167,111 | 89,231 | 49,880 | 31,991 | 28,216 |
Income taxes - deferred | N/A | N/A | N/A | 3,586 | 3,200 |
Other current assets | 1,148 | 516 | 0 | 0 | 0 |
TOTAL | $392,911 | $280,245 | $188,541 | $279,019 | $113,424 |
Non-Current Assets | |||||
PPE Net | 364,806 | 209,508 | 165,475 | 127,775 | 135,519 |
Intangibles | 396,430 | 289,675 | 94,326 | 3,042 | 3,065 |
Other Non-Current Assets | 55,501 | 86,139 | 67,526 | 35,432 | 10,854 |
TOTAL | $816,737 | $585,322 | $327,327 | $166,249 | $149,438 |
Total Assets | $1,209,648 | $865,567 | $515,868 | $445,268 | $262,862 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 36,432 | 15,591 | 447 | 1,024 | 776 |
Accounts payable and accrued liabilities | 111,147 | 60,890 | 32,160 | 24,179 | 18,194 |
Accrued Expenses | 11,743 | 7,897 | 4,235 | 6,806 | 5,786 |
Other current liabilities | N/A | N/A | 327 | 1,351 | 2,717 |
TOTAL | $175,518 | $99,096 | $48,690 | $48,849 | $35,986 |
Non-Current Liabilities | |||||
Long Term Debt | 604,476 | 373,692 | 155,895 | 123,135 | 7,227 |
Deferred Revenues | 13,370 | 14,718 | 11,171 | 6,588 | 7,365 |
Other Non-Current Liabilities | 86,845 | 86,195 | 69,461 | 29,970 | 9,898 |
TOTAL | $735,148 | $479,248 | $225,356 | $155,662 | $20,735 |
Total Liabilities | $910,666 | $578,344 | $274,046 | $204,511 | $56,721 |
Shareholders' Equity | |||||
Shares Outstanding, K | 42,941 | 35,829 | 32,745 | 32,328 | 31,337 |
Common Shares | 485 | 411 | 381 | 370 | 363 |
Retained earnings | 7,160 | 77,331 | 79,632 | 82,910 | 75,177 |
Other shareholders' equity | -40,159 | -18,856 | -14,065 | -11,329 | -10,183 |
TOTAL | $298,982 | $287,223 | $241,822 | $240,757 | $206,141 |
Total Liabilities And Equity | $1,209,648 | $865,567 | $515,868 | $445,268 | $262,862 |